Seven Months of CBD Improved Memory and Reduced Brain Inflammation in Aging Mice
Aging mice treated with oral CBD for seven months showed reduced brain inflammation and improved cognitive performance compared to untreated controls.
Quick Facts
What This Study Found
Fourteen-month-old mice given oral CBD for 7 months showed reduced inflammatory response in the brain and improvements in age-related cognitive decline when tested between 19-21 months of age across tasks measuring perirhinal cortex, hippocampal, amygdala, and motor function.
Key Numbers
CBD administered orally starting at 14 months of age. Testing at 19-21 months (equivalent to elderly in human terms). Tasks tested perirhinal cortex, hippocampus, amygdala, and motor coordination.
How They Did This
Controlled animal study administering oral CBD to 14-month-old C57 mice for 7 months, followed by behavioral testing across multiple cognitive and motor tasks sensitive to different brain regions.
Why This Research Matters
There are currently no approved medications for age-related cognitive decline. If CBD can reduce neuroinflammation and preserve cognition in aging brains, it could represent a widely accessible preventive approach.
The Bigger Picture
Neuroinflammation is increasingly recognized as a driver of age-related cognitive decline. CBD's anti-inflammatory properties may address a root cause rather than just symptoms, which is what most current approaches attempt.
What This Study Doesn't Tell Us
Animal study with significant translational gap to humans. Specific CBD dose not stated in abstract. No dose-response comparison. Mouse aging does not perfectly model human cognitive decline. Long treatment duration may not be practical.
Questions This Raises
- ?What is the minimum effective dose and duration of CBD for cognitive protection?
- ?Would these effects translate to humans?
- ?At what age should CBD supplementation begin to be most effective?
Trust & Context
- Key Stat:
- 7 months of oral CBD reduced brain inflammation and improved cognition in aging mice
- Evidence Grade:
- Well-designed long-term animal study with multiple behavioral outcomes, but significant translational gap to human aging.
- Study Age:
- 2025 animal study with relevance to the growing interest in CBD for age-related cognitive decline.
- Original Title:
- Effects of cannabidiol (CBD) treatment on age-related cognitive decline in C57 mice.
- Published In:
- Frontiers in aging neuroscience, 17, 1567650 (2025)
- Authors:
- Mirza Agha, Behroo, Monteith, Merrin(2), Earl, Jarem, Ganske, Keona, Kaloa, Tina, McDonald, Kelan J, Nixon, Abigail G, Panjwani, Maleeha, Robinson, Danika, Rusnak, Valeria, Mohajerani, Majid H, Kovalchuk, Igor, Sutherland, Robert J, Hong, Nancy S, McDonald, Robert J
- Database ID:
- RTHC-07150
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Can CBD prevent age-related memory loss?
In this mouse study, long-term oral CBD reduced brain inflammation and improved cognitive function in elderly mice. However, animal results do not always translate to humans, and human clinical trials are needed.
How might CBD protect the aging brain?
The study points to reduced neuroinflammation as the likely mechanism. Chronic brain inflammation is increasingly linked to cognitive decline with aging, and CBD has well-documented anti-inflammatory properties.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07150APA
Mirza Agha, Behroo; Monteith, Merrin; Earl, Jarem; Ganske, Keona; Kaloa, Tina; McDonald, Kelan J; Nixon, Abigail G; Panjwani, Maleeha; Robinson, Danika; Rusnak, Valeria; Mohajerani, Majid H; Kovalchuk, Igor; Sutherland, Robert J; Hong, Nancy S; McDonald, Robert J. (2025). Effects of cannabidiol (CBD) treatment on age-related cognitive decline in C57 mice.. Frontiers in aging neuroscience, 17, 1567650. https://doi.org/10.3389/fnagi.2025.1567650
MLA
Mirza Agha, Behroo, et al. "Effects of cannabidiol (CBD) treatment on age-related cognitive decline in C57 mice.." Frontiers in aging neuroscience, 2025. https://doi.org/10.3389/fnagi.2025.1567650
RethinkTHC
RethinkTHC Research Database. "Effects of cannabidiol (CBD) treatment on age-related cognit..." RTHC-07150. Retrieved from https://rethinkthc.com/research/mirza-2025-effects-of-cannabidiol-cbd
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.